An updated patent review of p38 MAP kinase inhibitors (2014-2019)

dc.contributor.author	Haller, Vanessa
dc.contributor.author	Nahidino, Philipp
dc.contributor.author	Forster, Michael
dc.contributor.author	Laufer, Stefan
dc.date.accessioned	2020-09-22T14:45:44Z
dc.date.available	2020-09-22T14:45:44Z
dc.date.issued	2020
dc.identifier.issn	1744-7674
dc.identifier.uri	http://hdl.handle.net/10900/107054
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/13543776.2020.1749263	de_DE
dc.subject.ddc	540	de_DE
dc.subject.ddc	610	de_DE
dc.title	An updated patent review of p38 MAP kinase inhibitors (2014-2019)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_00776
utue.publikation.seiten	453-466	de_DE
utue.personen.roh	Haller, Vanessa
utue.personen.roh	Nahidino, Philipp
utue.personen.roh	Forster, Michael
utue.personen.roh	Laufer, Stefan A.
dcterms.isPartOf.ZSTitelID	Expert Opinion on Therapeutic Patents	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE